PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

Keith Dredge, Ian Bytheway, Paul Handley et al.|British Journal of Cancer|2011

Cited by 165